Allogene Therapeutics Reports First Quarter 2019 Financial Results

Go back to Allogene Therapeutics Reports First Quarter 2019 Financial Results
(NASDAQ: ALLO) Delayed: 1.74 -0.08 (4.4%)
Previous Close $1.82    52 Week High
Open $1.83    52 Week Low
Day High $1.84    P/E N/A 
Day Low $1.74    EPS
Volume 4,856,472